CD8A and neoplasm: Numerous studies have highlighted the effectiveness of dual blockade, encompassing DNA sensing, DC cross-presentation, augmentation in stem-like progenitor CD8 T cells, thereby leading to an enhanced anti-tumor response [153,154,155,156].